Health and Life Sciences news
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Beyond COVID-19: New technologies, treatments could help recovered survivors now facing neurological aftereffects
Globally about 50 million people have been diagnosed with COVID-19, 1.2 million have died from the virus and 36.5 million have recovered, according to the World Health Organization.
Parkinson’s patients use telehealth access for immediate speech improvement during COVID-19 pandemic
SpeechVive Inc. announced Thursday (Nov. 19) it is making its remote calibration software and training available free during the COVID-19 global health crisis. The software and training are available to all speech-language pathologists and their patients, as well as Veterans Affairs medical centers and veterans with Parkinson’s disease.
Umoja Biopharma, a Purdue University-affiliated biotechnology company focused on using a patient’s own immune cells to kill cancerous cells, has secured one of the largest initial rounds of funding ever for a Purdue-affiliated company.
Pearls have long been favored as objects of beauty. Now, Purdue University innovators are using the gem to provide potential new opportunities for spectral information processing that can be applied to spectroscopy in biomedical and military applications.
Up to 22% of soccer injuries are concussions that can result from players using their heads to direct the ball during a game.
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.